Double-blind, 3 parallel randomized groups, therapeutic confirmatory. Clinical trial to compare the efficacy of levocetirizine 5 mg and montelukast 10 mg to placebo in reducing SAR symptoms in ragweed sensitive subjects in an EEU.

Trial Profile

Double-blind, 3 parallel randomized groups, therapeutic confirmatory. Clinical trial to compare the efficacy of levocetirizine 5 mg and montelukast 10 mg to placebo in reducing SAR symptoms in ragweed sensitive subjects in an EEU.

Completed
Phase of Trial: Phase IV

Latest Information Update: 30 Oct 2014

At a glance

  • Drugs Levocetirizine; Montelukast
  • Indications Seasonal allergic rhinitis
  • Focus Therapeutic Use
  • Sponsors UCB
  • Most Recent Events

    • 11 Jul 2007 Status change from in progress to completed.
    • 27 Oct 2006 Status change
    • 30 Sep 2006 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top